Kazuhiro Chiba
Corporate Officer/Principal chez Tokyo University of Agriculture & Technology
Postes actifs de Kazuhiro Chiba
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Tokyo University of Agriculture & Technology | Corporate Officer/Principal | - | - |
Historique de carrière de Kazuhiro Chiba
Anciens postes connus de Kazuhiro Chiba
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KEWPIE CORPORATION | Corporate Officer/Principal | - | - |
Jitsubo Co., Ltd.
 Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | 08/04/2005 | - |
| Directeur Technique/Scientifique/R&D | 08/04/2005 | - | |
| Fondateur | 08/04/2005 | - |
Formation de Kazuhiro Chiba
| Tokyo University of Agriculture & Technology | Graduate Degree |
Statistiques
Internationale
| Japon | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
| Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KEWPIE CORPORATION | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |
- Bourse
- Insiders
- Kazuhiro Chiba
- Expérience
